Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
1 Reason to Sell DexCom Stock, and 1 Reason to Buy
06:45am, Saturday, 21'st Dec 2024
Shares of the medical-device maker DexCom (DXCM 5.57%) are down by 37% this year. The diabetes-focused healthcare company disappointed investors with its second-quarter results, leading to a massive d
2025 Picks: 2 Stocks to Buy Now for 50% Upside
09:01am, Friday, 20'th Dec 2024
Two S&P 500 stocks--DexCom and Albemarle--are already on sale for investors to buy in 2025.
Diabetes Brands Dexcom, Ozempic, Mounjaro Drive Q3 Convergent TV Ad Engagement
08:30am, Thursday, 19'th Dec 2024
NEW YORK--(BUSINESS WIRE)--EDO, the TV outcomes company, has released its Q3 2024 Diabetes Convergent TV Outcomes Report, providing critical insights into the diabetes category linear and streaming TV
DXCM Stock Gains on the Launch of Proprietary Generative AI Platform
11:35am, Wednesday, 18'th Dec 2024
Dexcom announces the first Generative AI platform in glucose biosensing.
Dexcom's over-the-counter glucose monitor now offers users an AI summary of how sleep, meals and more impact sugar levels
09:00am, Tuesday, 17'th Dec 2024
Dexcom on Tuesday announced its first generative AI feature for its Stelo biosensor that gives users a personalized weekly report about their glucose. The company has been building a generative AI pla
Dexcom Launches the First Generative AI Platform in Glucose Biosensing
09:00am, Tuesday, 17'th Dec 2024
SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, announced today it has launched a proprietary Generative AI (GenAI) platform, making Dexcom the first C
BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), a global leader in glucose biosensing technology, is proud to announce that the Dexcom G7 Continuous Glucose Monitoring (CGM) S
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now
09:01am, Friday, 13'th Dec 2024
DXCM continues to raise optimism among investors owing to its strong product portfolio.
DexCom: Brighter 2025 From Stelo Ramp
03:18pm, Tuesday, 10'th Dec 2024
DexCom faces challenges in 2024 due to competition and missteps, but the long-term outlook for continuous glucose monitors remains strong. Q3 revenue grew only 2% y/y to $994.2 million, with temporary
11 Ultra SWAN Bargains That Could Thrive As The Market Soars To Record Highs
07:00am, Thursday, 05'th Dec 2024
The S&P is up 27% in 2024, including a 5.5% rally in November. The Euphoria index is at record highs, indicating investor sentiment is extremely bullish. While 2025 is likely to see much larger volati
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
09:12am, Monday, 02'nd Dec 2024
Medical device specialist DexCom (DXCM -0.14%) is going through a rough patch. The company's shares are down sharply year to date due to unimpressive financial results -- and some of the headwinds it
2 Excellent Healthcare Stocks to Hold Through the Next Decade
07:45am, Thursday, 28'th Nov 2024
Although excellent medical care is always in high demand, the healthcare sector continuously evolves. Companies aren't automatically worth investing in just because they provide essential medical serv
Why DexCom (DXCM) is a Top Momentum Stock for the Long-Term
10:55am, Tuesday, 26'th Nov 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These Are the 5 Worst-Performing Stocks in the Nasdaq-100 With 2024 Almost Over
07:30am, Tuesday, 26'th Nov 2024
The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes ( S&P 500 , Nasdaq Composite, a
2 Superior Growth Stocks to Buy Right Now If You have $1,000 to Invest
10:15am, Sunday, 24'th Nov 2024
It's not always easy to be a long-term investor, particularly when contending with the natural cyclicality that the stock market presents if you buy and hold through bull as well as bear markets.
